COMMUNIQUÉS West-GlobeNewswire

Yield10 Bioscience Exercises Option with University of Missouri to Obtain Exclusive Worldwide License to Advanced Technologies for Oilseed Crops

22/05/2018 - 14:30

WOBURN, Mass., May 22, 2018 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN ), a Company developing new technologies to achieve step-change improvements in crop yield to enhance global food security, today [...]

Zosano Appoints Steven A. Elms to Board of Directors

22/05/2018 - 14:30

FREMONT, Calif., May 22, 2018 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ: ZSAN ) (“Zosano” or the “Company”) a clinical-stage biopharmaceutical company focused on providing rapid systemic administration of [...]

Progenics Announces JAMA Oncology Publication Highlighting Company’s Imaging Analysis Platform

22/05/2018 - 14:30

Data Support Prognostic Utility of aBSI as an Imaging Biomarker for Survival in Patients with Castration-Resistant Prostate Cancer NEW YORK, May 22, 2018 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX [...]

Oxford Immunotec Announces Launch of the Accutix™ Brand

22/05/2018 - 14:30

OXFORD, United Kingdom and MARLBOROUGH, Mass., May 22, 2018 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq: OXFD ), a global, high-growth diagnostics company, today announced the launch of the Accutix brand for [...]

BioDelivery Sciences Announces Closing of $50 Million Equity Financing and Appointment of Peter Greenleaf as Chairman of the Board

22/05/2018 - 14:29

RALEIGH, N.C., May 22, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI ) today announced it has closed its previously announced $50 million registered direct offering of newly designated [...]

Novo Nordisk A/S - Share repurchase programme

22/05/2018 - 14:27

Bagsværd, Denmark, 22 May 2018 - On 4 May 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR), [...]

Kane Biotech Appoints Pharmaceutical Executive Rashieda Gluck to Board of Directors

22/05/2018 - 14:23

WINNIPEG, Manitoba, May 22, 2018 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V: KNE ) (OTCQB:KNBIF), (the “Corporation” or “Kane Biotech”) is pleased to announce it has appointed Rashieda (Rivka) Gluck to the Corporation [...]

Delcath Sponsors Looking For A Cure Ocular Melanoma Charity Event

22/05/2018 - 14:15

NEW YORK, May 22, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTHD), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, is proud to sponsor A Cure In Sight [...]

Share buy-back week 20/2018

22/05/2018 - 14:10

Announcement 22 May 2018 Coloplast – transactions in connection with share buy-back programme As mentioned in Announcement No. 3/2018 Coloplast has initiated the first part of the share buy-back programme totalling up [...]

FDA to review Zynquista™ (sotagliflozin) as potential treatment for type 1 diabetes

22/05/2018 - 14:03

BRIDGEWATER, N.J. and THE WOODLANDS, Texas, May 22, 2018 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration (FDA) has accepted Sanofi’s regulatory filing for Zynquista (sotagliflozin). The investigational oral [...]

Cognition Therapeutics Receives $6.6M in NIA Grants for Two Studies of Elayta™ to Expand Understanding of Synaptoprotective Mechanism of Action

22/05/2018 - 14:02

PITTSBURGH, May 22, 2018 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. , a clinical stage neuroscience company focused on the development of innovative therapeutics for the treatment of Alzheimer’s disease and other [...]

Innovate Biopharmaceuticals Scheduled to Present at BIO 2018 Convention in Boston on Tuesday, June 5, 2018, at 4:45PM

22/05/2018 - 14:01

RALEIGH, N.C., May 22, 2018 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (“Innovate”) (Nasdaq: INNT ), a clinical stage biotechnology company focused on developing novel therapeutics for immuno-inflammatory [...]

Emerald Health Therapeutics to Present at Upcoming Investor Conferences

22/05/2018 - 14:00

Presentation will be webcasted and archived VICTORIA, British Columbia, May 22, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (TSXV:EMH) (OTCQX:EMHTF) (Emerald) today announced that members of its executive [...]

MRI Interventions to Present at the LD Micro Invitational Conference on June 5

22/05/2018 - 14:00

IRVINE, Calif., May 22, 2018 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC) today announced that Chief Executive Officer Joe Burnett will present at the 8th annual LD Micro Invitational on Tuesday, June 5 at [...]

Chembio Diagnostics and Massachusetts General Hospital Enter Memorandum Of Understanding to Develop Point-of-Care Fever Diagnostic Test

22/05/2018 - 14:00

MEDFORD, N.Y., May 22, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI ), a leader in point-of-care ("POC") diagnostic tests for infectious diseases, today announced that it has entered a non-binding [...]

Progressive Care Purchases TCGRx Pouch Packaging System to Add to Expanding Robot Pharmacy Machinery Fleet

22/05/2018 - 14:00

MIAMI, May 22, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB:RXMD), a personalized healthcare services and technology company, today announced that the company has purchased a new TCGRx Automated Pouch Packaging [...]

The Integrated Healthcare Association (IHA) Selects Gaine Healthcare and Availity to Support the Launch of the California Statewide Provider Directory Utility

22/05/2018 - 14:00

Selection of leading technology partners and participation of three large California network plans positions IHA well for success and scale OAKLAND, Calif., May 22, 2018 (GLOBE NEWSWIRE) -- The Integrated Healthcare [...]

XBiotech Announces First Patient in Phase 2 Study Evaluating MABp1 in Patients with Atopic Dermatitis

22/05/2018 - 14:00

First Patient Begins Therapy with MABp1 for Treatment of Atopic Dermatitis AUSTIN, Texas, May 22, 2018 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT ) announced today that the first patient has been enrolled in its [...]

Incysus Moves Its Corporate Domicile to Delaware

22/05/2018 - 14:00

NEW YORK, May 22, 2018 (GLOBE NEWSWIRE) -- Incysus, Ltd., a biopharmaceutical company focused on delivering an innovative gamma-delta (γδ) T cell immunotherapy for the treatment of cancers, announced that effective May [...]